Pregabalin Lyrica Raw Materials relieve Neuropathic pain and Anxiety disorders

Pregabalin Lyrica Raw Materials relieve Neuropathic pain and Anxiety disorders

Outline

CAS: 148553-50-8
MF: C8H17NO2
MW: 159.23
Essai: 99.5%
Apparence: Poudre de cristal blanc
Paiement: T/T, Western Union et Money Gram
Livraison: Dans les 24 heures après votre paiement

Neuropathic pain introduction

The European Federation of Neurological Societies recommends pregabalin as a first line agent for the treatment of pain associated with diabetic neuropathy, post-herpetic neuralgia, and central neuropathic pain. A minority obtain substantial benefit, and a larger number obtain moderate benefit. Other first line agents, including gabapentin and tricyclic antidepressants, are given equal weight as first line agents and, unlike pregabalin, are available as less expensive generics.

Anxiety disorders

The World Federation of Biological Psychiatry recommends pregabalin as one of several first line agents for the treatment of generalized anxiety disorder, but recommends other agents such asSSRIs as first line treatment for obsessive-compulsive disorder and post-traumatic stress disorder.It appears to have anxiolytic effects similar to benzodiazepines with less risk ofdependence.Therapeutic effects of pregabalin appear after 1 week of use and is similar in effectiveness to venlafaxine, but pregabalin has demonstrated superiority by producing more consistent therapeutic effects for psychic and somatic anxiety symptoms.Long-term trials have shown continued effectiveness without the development of tolerance, et, en outre, unlike benzodiazepines, it has a beneficial effect on sleep and sleep architecture, characterized by the enhancement of slow-wave sleep. and produces less severe cognitive and psychomotor impairment;